We recently posted a Quick Read on what we know about the potential introduction of international reference pricing (often abbreviated to IRP) in the USA.
Since then, Politico has published an article that claims the Trump administration has now asked for proposals to introduce a Most Favored Nation policy. Whereas before we were citing think tanks, now news outlets are suggesting the Trump administration itself is actively considering international reference pricing.
What does this mean for you?
If you were waiting for more clarity before taking action, wait no more. We are one step closer to a huge shakeup in the pharma pricing landscape.
Start preparing by simulating all possible USA IRP mechanisms to see the impact on your global revenues.
Get in touch to learn more about how we can help you. Or, read more about our IRP and launch sequence optimization simulators.